Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Aug 15, 2026; 18(8): 120942
Published online Aug 15, 2026. doi: 10.4251/wjgo.120942
Published online Aug 15, 2026. doi: 10.4251/wjgo.120942
Table 1 Correlation between the tumor regression grade and post-neoadjuvant chemotherapy TP53 circulating tumor DNA status, n (%)
| Variables | Total (n = 9) | TRG 1 (n = 2) | TRG 2 (n = 4) | TRG 3 (n = 3) | P value |
| Post-NCT TP53 ctDNA | 0.012 | ||||
| - | 6 (66.67) | 2 (100.00) | 4 (100.00) | 0 (0.00) | |
| + | 3 (33.33) | 0 (0.00) | 0 (0.00) | 3 (100.00) | |
- Citation: Gu RT, Liu T, Piao ZS, Jin H, Wang XW, Li X. Quantitative TP53 circulating tumor DNA predicts tumor response and survival outcomes in esophageal squamous cell carcinoma. World J Gastrointest Oncol 2026; 18(8): 120942
- URL: https://www.wjgnet.com/1948-5204/full/v18/i8/120942.htm
- DOI: https://dx.doi.org/10.4251/wjgo.120942